Canada· CA-DIN-02247238
ELIDEL
A pimecrolimus product containing pimecrolimus, registered in Canada by BAUSCH HEALTH, CANADA INC.. The same ATC class is registered in 13 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Pimecrolimus is registered in 13 of 19 countries.
Countries holding a registration under ATC D11AH02 (pimecrolimus), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 8 of them publish a price we can compare per daily dose
Pimecrolimus · ATC D11AH02
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- PIMECROLIMUS
- Manufacturer
- BAUSCH HEALTH, CANADA INC.
- Country
- Canada (CA)
- ATC code
- D11AH02
- ATC class
- Pimecrolimus
- Defined daily dose
- 20 mg, T
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
217 interactions on record for pimecrolimus.
Graded by severity as the source publishes them — 9 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Pimecrolimus · interactions on record
217 records
- 9 moderate
- 83 minor
- 125 info
Most severe, free to view
- FostamatinibB02BX09moderate
- EchinaceaD03AH02moderate
- TemsirolimusL01EG01moderate
- SirolimusL01EG04moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Pimecrolimus in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- PolandElidelViatris Healthcare Sp. z o.o.
- United StatespimecrolimusActavis Pharma, Inc.
- CzechiaELIDELVIATRIS HEALTHCARE LIMITED, Dublin
- United KingdomElidel 1% creamViatris UK Healthcare Ltd
- SwitzerlandElidel
- FinlandElidelViatris Oy
- SwedenElidel 10 mg/g KrämOrifarm AB
- IcelandElidelViatris ApS
Authorised across Europe · EMA
The same active substance is authorised in 28 EEA countries. Names it is sold under:
- Austria · Elidel
- Belgium · Elidel
- Bulgaria · Елидел
- Cyprus · Elidel
- Czechia · Elidel
- Germany · Elidel
- Denmark · Elidel
- Estonia · Elidel
- Spain · Elidel
- Finland · Elidel
- United Kingdom (Northern Ireland) · Elidel
- Greece · Elidel
- Croatia · Elidel
- Hungary · Elidel
- Iceland · Elidel
- Italy · Elidel
- Lithuania · Elidel
- Luxembourg · Elidel
- Latvia · Elidel
- Malta · Elidel
- Netherlands · Elidel
- Norway · Elidel
- Poland · Elidel
- Portugal · Elidel
- Romania · Elidel
- Sweden · Elidel
- Slovenia · Elidel
- Slovakia · Elidel
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c1c6bf59-6904-40bb-894f-b8ad4936ad40 GET /v1/drugs/c1c6bf59-6904-40bb-894f-b8ad4936ad40?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02247238",
"form": "CREAM",
"class": "Human",
"routes": [
"TOPICAL"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "D11AH02",
"schedule": [
"Prescription"
],
"drug_code": "71480",
"strengths": [
"1 %"
],
"ahfs_class": null,
"substances": [
"PIMECROLIMUS"
],
"product_categorization": null
}See everything about pimecrolimus.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.